Phagenesis
Developer of neurostimulation system to treat swallowing dysfunction.
6
Funding Rounds
$95.3m
Money raised
Funding
Funding series
Funding Series Analysis
The company Phagenesis has raised a total of $95.33m in funding over 6 rounds.
Key Insights:
- Phagenesis March 2024 Series D Funding Round: $42m
- Phagenesis May 2013 Series B Funding Round: $17m
- Phagenesis Series B round, May 2013: $17m
- Phagenesis October 2011 Series B Funding Round: $7.6m
- Phagenesis Series B round, October 2011: $9.23m
- Phagenesis September 2010 Series A Funding Round: $2.5m
Phagenesis March 2024 Series D Funding Round
$42m
Phagenesis May 2013 Series B Funding Round
$17m
Phagenesis Series B round, May 2013
$17m
Phagenesis October 2011 Series B Funding Round
$7.6m
Phagenesis Series B round, October 2011
$9.23m
Phagenesis September 2010 Series A Funding Round
$2.5m
Industries
Phagenesis is active in the following industries: